Best PET-CT with Gallium 68 (DOTATATE) Doctors in Israel — TOP 12

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Professor Ido Nachmany is a Forbes-ranked top physician in Israel. He heads the General Surgery Department at the prestigious Sheba Medical Center.

• Specializes in gastrointestinal neuroendocrine tumors (NETs) requiring PET-CT with Gallium 68 diagnostics
• Trained in abdominal transplantation and hepatopancreatobiliary surgery in the USA
• Senior Lecturer at the Tel Aviv University Faculty of Medicine
• Member of the International Hepato-Pancreato-Biliary Association
• Author of numerous publications in the European Journal of Surgical Oncology

Dr. Almog Ben Yaacov is a senior oncological surgeon at Sheba Medical Center. He specializes in the surgical treatment of complex cancers identified by PET-CT with Gallium 68.

• Trained in surgical oncology at Memorial Sloan Kettering Cancer Center in New York
• Completed specialized training in liver ablation and NanoKnife technology in Europe
• Serves as a senior surgeon focusing on gastric, colorectal, and abdominal malignancies
• Expertise in cytoreductive surgery to remove visible tumor masses within the abdomen
• Performed over 200 HIPEC procedures – applying heated chemotherapy directly during surgery

Prof. Amit Tirosh heads the Neuroendocrine Tumors Service at Sheba Medical Center. He uses PET-CT with Gallium 68 (DOTATATE) to locate and stage complex endocrine tumors.

• Trained in neuroendocrine tumors and genetics at the National Institutes of Health.
• Contributed to international clinical guidelines for treating von Hippel–Lindau disease.
• Author of 40+ peer-reviewed publications in journals like JAMA and Radiology.
• Member of the European Neuroendocrine Tumors Society and American Endocrine Society.
• Leads a specialized laboratory focusing on bioinformatics in endocrine oncology.

Dr. Blachar Arye is a radiologist at Sourasky Medical Center specializing in cancer imaging. He focuses on diagnosing liver, lung, and prostate cancers. Forbes Israel magazine named him one of the country's best physicians. He trained at Harvard and the University of Pennsylvania.

• Expert in CT colonography and hepatic perfusion imaging.
• Awarded Magna Cum Laude for research on portal vein thrombosis.
• Fellow of the European Society of Gastrointestinal and Abdominal Radiology.
• Works at Sourasky Medical Center, ranked among the world's most popular clinics.

Dr. Einat Even-sapir is the Head of Nuclear Medicine at Sourasky Medical Center. She treats over 400,000 patients annually at this facility. Dr. Even-sapir is an expert in hybrid, oncologic, and molecular breast imaging. She holds both an MD and a PhD in medical sciences.

• Specializes in PET-CT, PET-MRI, and molecular diagnostic techniques.
• Completed medical training at Tel Aviv University and the Technion.
• Conducted clinical research and further studies at Dalhousie University in Canada.
• Works at a clinic ranked among the Top 10 most popular for tourists.

Prof. Boursi specializes in gastrointestinal oncology at Sheba Medical Center. He uses detailed imaging like PET-CT with Gallium 68 to find neuroendocrine tumors.

• Completed advanced subspecialty training at the University of Pennsylvania in the USA
• Trained in medical oncology at the world-renowned MD Anderson Cancer Center
• Fellowship graduate from the Mayo Clinic with focus on complex cancer cases
• Internationally recognized leader who publishes research in the prestigious journal Science
• Member of the American Society for Cancer Research

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Prof. Gil Raviv, MD, PhD, is Director of the Andrology Unit at Sheba Medical Center. He was listed among the Best Doctors in Israel by Forbes in 2024. He is a leading expert in male fertility, sexual medicine, and reconstructive urology.

His primary focus is male infertility and fertility preservation. He performs advanced semen analysis according to WHO standards. He carries out testicular sperm retrieval (TESE, TESA, MESA) and semen cryopreservation. He also provides comprehensive fertility diagnostics with histological analysis.

He is a Professor at Tel Aviv University. He trained in Siena, Rome, and Tel Aviv. He completed a fellowship in infertility and impotence at Erasme Hospital. He received advanced training in reconstructive urethral surgery in Ghent. He is a member of the European Association of Urology, the International Society for Sexual Medicine, and the Israeli Urological Association.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.